开放期刊系统

T 细胞在新型冠状病毒感染中的作用

王 铭渝, 王 道涵, 朴 美花

摘要

新型冠状病毒(SARS-CoV-2)是新型冠状病毒感染(COVID-19)的病原体,最近几年SARS-CoV-2及其变异株在全球
范围内的流行对世界卫生安全造成了巨大的威胁。免疫系统与病毒的相互作用是影响患者临床症状严重程度以及预后的
重要因素,也一直都是相关研究的重点。T细胞作为机体适应性免疫反应的重要组成部分,在COVID-19的各个阶段都
发挥着重要的作用。本文将阐述COVID-19患者在各个阶段T细胞反应的动态变化及影响因素并探讨T细胞检测在预防和
治疗COVID-19中的应用。

关键词

T细胞;新型冠状病毒;新型冠状病毒感染;适应性免疫

全文:

PDF

参考

[1]MOSS P. The T cell immune response against SARS-CoV-2[J/OL].Nature Immunology,2022,23(2):186-193.

[2]AMERATUNGA R,WOON S T,JORDAN A,et al. Perspective:diagnostic laboratories should urgently develop T cell assays for

SARS-CoV-2 infection[J/OL].Expert Review of Clinical Immunology,2021,17(5):421-430.

[3]VARDHANA S,BALDO L,MORICE W G,et al. Understanding T cell responses to COVID-19 is essential for informing public

health strategies[J/OL].Science Immunology,2022,7(71).

[4]SWAIN S L,MCKINSTRY K K,STRUTT T M. Expanding roles for CD4⁺T cells in immunity to viruses[J/OL].Nature Reviews

Immunology,2012,12(2):136-148.

[5]CUI D,TANG Y,JIANG Q,et al. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection[J/OL].Front

Immunol. 2021,12:731100

[6]KANEKO N,BOUCAU J,KUO H H,et al. Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs

in severe COVID-19[J/OL].Clinical Immunology,2022,237:108991.

[7]RYDYZNSKI MODERBACHER C,RAMIREZ S I,DAN J M,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute

COVID-19 and Associations with Age and Disease Severity[J/OL].Cell,2020,183(4):996-1012.e19.

[8]HOFT MA,BURGERS WA,RIOU C. The immune response to SARS-CoV-2 in people with HIV[J/OL].Cell Mol Immunol,2024,

21(2):184-196.

[9]ZHANG B,ZHOU X,ZHU C,et al. Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts

Disease Severity and Outcome for Patients With COVID-19[J/OL].Front Mol Biosci,2020,7:157.

[10]PENG Y,MENTZER A J,LIU G,et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK

convalescent individuals following COVID-19 [J/OL].Nature Immunology,2020,21(11):1336-1345.

[11]ZHAO Q,MENG M,KUMAR R,et al. Lymphopenia is associated with severe coronavirus disease 2019(COVID-19)infections:

A systemic review and meta-analysis[J/OL].International Journal of Infectious Diseases,2020,96:131-135.

[12]LEE J S,PARK S,JEONG H W,et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in

development of severe COVID-19[J/OL].Science Immunology,2020,5(49):eabd1554.

[13]SEKINE T,PEREZ-POTTI A,RIVERA-BALLESTEROS O,et al. Robust T Cell Immunity in Convalescent Individuals with

Asymptomatic or Mild COVID-19[J/OL],Cell,2020:158-168.

[14]DAN J M,MATEUS J,KATO Y,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after

infection[J/OL].Science. 2021,371(6529):eabf4063

[15]VISVABHARATHY L,HANSON B A,ORBAN Z S,et al. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+T

cell responses to SARS-CoV-2 Nucleocapsid protein[J/OL].Front Immunol. 2023,14:1155770.


(0 摘要 Views, 0 PDF Downloads)

Refbacks

  • 当前没有refback。